Emerging targets for the development of novel antifungal therapeutics

This publication has 54 references indexed in Scilit:

• Potential new antifungal agents
  Current Opinion in Infectious Diseases, 1997
• Invasive Aspergillosis in Mice Immunosuppressed with Cyclosporin A, Tacrolimus (FK506), or Sirolimus (Rapamycin)
  The Journal of Infectious Diseases, 1997
• Identification of Yeast Rho1p GTPase as a Regulatory Subunit of 1,3-β-Glucan Synthase
  Science, 1996
• Protein Kinase N (PKN) and PKN-Related Protein Rhophilin as Targets of Small GTPase Rho
  Science, 1996
• Identification of six complementation classes involved in the biosynthesis of glycosylphosphatidylinositol anchors in Saccharomyces cerevisiae.
  The Journal of cell biology, 1995
• Translation elongation factor-3 (EF-3): An evolving eukaryotic ribosomal protein?
  Journal of Molecular Evolution, 1995
• Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1995
• Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals
  Current Genetics, 1995
• Yeast genes involved in growth inhibition byPseudomonas syringaepv.syringaesyringomycin family lipodepsipeptides
  FEMS Microbiology Letters, 1993
• Pseudomycins, a family of novel peptides from Pseudomonas syringae possessing broad-spectrum antifungal activity.
  Journal of General Microbiology, 1991